Scholarly Index
Robert Yarchoan
National Cancer Institute; 25,249 total citations; 402 total publications; best world rank #36
National Cancer Institute
25,249Total citations
402Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Viral-associated cancers and disorders | Lifetime | 52 | US 25 | 99.50 |
| HIV/AIDS drug development and treatment | Lifetime | 96 | US 56 | 99.49 |
| Lymphoma Diagnosis and Treatment | Lifetime | 218 | US 114 | 99.31 |
| HIV Research and Treatment | Lifetime | 212 | US 137 | 99.34 |
| Cytomegalovirus and herpesvirus research | Lifetime | 193 | US 124 | 98.84 |
| Histiocytic Disorders and Treatments | Lifetime | 47 | US 30 | 98.58 |
| Parvovirus B19 Infection Studies | Lifetime | 137 | US 70 | 98.25 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 444 | US 193 | 97.72 |
| T-cell and Retrovirus Studies | Lifetime | 336 | US 165 | 96.81 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 281 | US 133 | 96.64 |
| Polyomavirus and related diseases | Lifetime | 684 | US 318 | 95.07 |
| Viral-associated cancers and disorders | 2021-2025 | 36 | US 19 | 97.67 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 385 | US 174 | 96.54 |
| Histiocytic Disorders and Treatments | 2021-2025 | 51 | US 32 | 88.36 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 278 | US 114 | 86.18 |